Trial Profile
A randomized, placebo-controlled, double-blind parallel-group study to evaluate the ocular and systemic safety and tolerability of repeated doses of propiverine hydrochloride in patients with primary Open-angle-glaucoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Apogepha
- 02 Jan 2017 New trial record